Navigation Links
Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available

Allergy Product in New Bubble Gum Flavor for Ages Two Years and Older

FT. WASHINGTON, Pa., Jan. 27 /PRNewswire/ -- McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., today announced the availability of Children's ZYRTEC(R) Allergy Bubble Gum Syrup, a new sugar-free, dye-free bubble gum flavor product used to treat perennial and seasonal allergic rhinitis, also known as upper respiratory allergies, in children ages two years and older. Children's ZYRTEC(R) Allergy Bubble Gum Syrup relieves kids' indoor and outdoor allergy symptoms. The new children's product is available in original prescription strength without a prescription in local retail stores starting today.

"The new sugar-free, dye-free children's allergy product offers the allergy relief of ZYRTEC(R) that parents have relied on for years, but without the addition of corn syrup or food dyes," said Rohinish Hooda, Vice President of Marketing, Upper Respiratory, McNeil Consumer Healthcare. "Children's ZYRTEC(R) Allergy Bubble Gum Syrup is an important addition to our pediatric portfolio to help parents manage their child's indoor and outdoor allergy symptoms."

Children's ZYRTEC(R) Allergy Bubble Gum Syrup, which is available in a convenient plastic bottle, received approval from the Food and Drug Administration in August 2008 to treat indoor and outdoor allergy symptoms for 24 hours. ZYRTEC(R) has a variety of products in different flavors and forms to help relieve children's allergy symptoms. These products are available in the original prescription strength without a prescription and include Children's ZYRTEC(R) Allergy Grape Syrup and sugar-free, dye-free Children's ZYRTEC(R) Allergy Bubble Gum Syrup for ages two years and older, as well as Children's ZYRTEC(R) Allergy Chewables for ages six years and older. ZYRTEC(R) also offers Children's ZYRTEC(R) Hives Relief Syrup for ages six years and older. For more information on Children's ZYRTEC(R) Allergy Bubble Gum Syrup and the portfolio of ZYRTEC(R) allergy products for adults and children, visit

About Allergies

More than 36 million Americans suffer from indoor and outdoor allergic rhinitis, also known as upper respiratory allergies. Up to 40 percent of children are affected by allergic rhinitis. In fact, on any given day, an estimated 10,000 American children miss school because of allergic rhinitis, for an annual total of two million lost school days. Allergies are caused when a person's immune system overreacts to normally harmless substances. These substances are often referred to as triggers. People can encounter indoor and outdoor allergy triggers anytime throughout the year that can lead to allergy symptoms. For children with allergies, the change of the seasons, sports, and even the school building itself can trigger symptoms like sneezing, runny nose and itchy-watery eyes.


ZYRTEC(R) is an antihistamine that helps block the action of histamine in the body. ZYRTEC(R) helps provide 24 hour relief of indoor and outdoor upper respiratory allergy symptoms including symptoms of sneezing, runny nose, and itchy-watery eyes. These symptoms can be caused by allergy triggers such as dust, mold and pet dander, tree pollen, weeds and grasses. ZYRTEC(R) offers a full line of products for adults, including ZYRTEC(R) tablets and ZYRTEC-D(R), as well as children. For more information about full line of ZYRTEC(R) products, visit

About McNeil Consumer Healthcare

McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., a subsidiary of Johnson & Johnson, markets a broad range of well-known and trusted over-the-counter (OTC) products. McNeil Consumer Healthcare is most widely recognized for the complete line of TYLENOL(R) acetaminophen products, the leading pain reliever brand in the adult and pediatric categories. The TYLENOL(R) product line consists of hundreds of products across a variety of pain categories including: arthritis pain, pain with accompanying sleeplessness and upper respiratory. Other McNeil Consumer Healthcare brands include BENADRYL(R) allergy medicine; IMODIUM(R) A-D anti-diarrheal; MOTRIN(R) IB; PediaCare(R) upper respiratory medicines for children; ROLAIDS(R) antacid products; ST. JOSEPH(R) Adult Regimen Aspirin; and SUDAFED(R) and SUDAFED PE(R) nasal decongestants.

    Teresa Panas                     Kathryn Ritzinger
    McNeil Consumer Healthcare       Cohn & Wolfe
    (908) 904-3198                   (212) 537-8217     

SOURCE McNeil Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
2. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
3. Siegel+Gale Designs New HOPE Portal for Childrens Hospital Los Angeles
4. Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles
5. National Childrens Study Begins Recruiting
6. FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
8. Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome
9. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
10. Clean to Ease Allergy and Asthma Symptoms
11. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: